National Academies Press: OpenBook
« Previous: 9 Creating a Blueprint for Action
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

References

Akksilp, S., W. Wattanaamornkiat, W. Kittikraisak, S. Nateniyom, S. Rienthong, C. Sirinak, K. Ngamlert, W. Mankatittham, W. Sattayawuthipong, S. Sumnapun, N. Yamada, P. Monkongdee, A. Anuwatnonthakate, C. Burapat, C. D. Wells, J. W. Tappero, and J. K. Varma. 2009. Multi-drug resistant TB and HIV in Thailand: Overlapping, but not independently associated risk factors. Southeast Asian Journal of Tropical Medicine and Public Health 40(6):1264-1278.

Andrews, R. H., S. Devadatta, W. Fox, S. Radhakrishna, C. V. Ramakrishnan, and S. Velu. 1960. Prevalence of tuberculosis among close family contacts of tuberculous patients in South India, and influence of segregation of the patient on early attack rate. Bulletin of the World Health Organization 23:463-510.

Arora, V. K., R. Sarin, R. Singla, U. K. Khalid, K. Mathuria, N. Singla, and V. P. Myneedu. 2007. DOTS-Plus for patients with multidrug-resistant tuberculosis in India: Early results after three years. Indian Journal of Chest Diseases and Allied Sciences 49:75-79.

Batra, S. 2011. Dramatic Results in TB Treatment: Building a Low Cost, Effective, Scalable and Replicable Model. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Becerra, M. C., S. C. Appleton, M. F. Franke, K. Chalco, F. Arteaga, J. Bayona, M. Murray, S. S. Atwood, and C. D. Mitnick. 2011. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: A retrospective cohort study. Lancet 377(9760):147-152.

Behera, D. 2011. HIV-MDR TB Co-Infection in India. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Boehme, C. C., P. Nabeta, D. Hillemann, M. P. Nicol, S. Shenai, F. Krapp, J. Allen, R. Tahirli, R. Blakemore, R. Rustomjee, A. Milovic, M. Jones, S. M. O’Brien, D. H. Persing, S. Ruesch-Gerdes, E. Gotuzzo, C. Rodrigues, D. Alland, and M. D. Perkins. 2010. Rapid molecular detection of tuberculosis and rifampicin resistance. New England Journal of Medicine 363(11):1005-1015.

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

Borrell, S., and S. Gagneux. 2009. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 13(12):1456-1466.

Brooks, S. M., N. L. Lassiter, and E. C. Young. 1973. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. American Review of Respiratory Disease 108(4):799-804.

Bwanga, F., S. Hoffner, M. Haile, and M. L. Joloba. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis. BMC Infectious Diseases 9:67.

Coker, R. J. 2004. Review: Multidrug-resistant tuberculosis: Public health challenges. Tropical Medicine and International Health 9(1):25-40.

Deivanayagam, C. N., S. Rajasekaran, R. Venkatesan, A. Mahilmaran, P. R. Ahmed, S. Annadurai, S. Kumar, C. Chandrasekar, N. Ravichandran, and R. Pencillaiah. 2002. Prevalence of acquired MDR-TB and HIV co-infection. Indian Journal of Chest Diseases and Allied Sciences 44(4):237-242.

Dewan, P. K., D. Gupta, B. G. Williams, R. Thakur, D. Bachani, A. Khera, D. F. Wares, S. Sahu, D. C. Reddy, N. Raizada, and L. S. Chauhan. 2010. National estimate of HIV seroprevalence among tuberculosis patients in India. International Journal of Tuberculosis and Lung Disease 14(2):247-249.

Drobac, P. C., J. S. Mukherjee, J. K. Joseph, C. Mitnick, J. J. Furin, H. del Castillo, S. S. Shin, and M. C. Becerra. 2006. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics 117(6):2022-2029.

Drobniewski, F., I. Eltringham, C. Graham, J. G. Magee, E. G. Smith, and B. Watt. 2002. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax 57(9):810-816.

Dye, C., and B. G. Williams. 2010. The population dynamics and control of tuberculosis. Science 328(5980):856-861.

Escombe, A. R., D. A. Moore, R. H. Gilman, W. Pan, M. Navincopa, E. Ticona, C. Martínez, L. Caviedes, P. Sheen, A. Gonzalez, C. J. Noakes, J. S. Friedland, and C. A. Evans. 2008. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Medicine 5(9):e188.

Fairlie, L., N. C. Beylis, G. Reubenson, D. P. Moore, and S. A. Madhi. 2011. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: A cross sectional study. BMC Infectious Diseases 11:28.

Fiegel, J., L. Garcia-Contreras, M. Thomas, J. VerBerkmoes, K. Elbert, A. Hickey, and D. Edwards. 2008. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. Pharmaceutical Research 25(4):805-811.

Frieden, T. R., P. I. Fujiwara, R. M. Washko, and M. A. Hamburg. 1995. Tuberculosis in New York City—Turning the tide. New England Journal of Medicine 333(4):229-233.

Gagneux, S., C. D. Long, P. M. Small, T. Van, G. K. Schoolnik, and B. J. Bohannan. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312(5782):1944-1946.

Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547):1575-1580.

Gandhi, N. R., S. Shah, J. R. Andrews, V. Vella, A. P. Moll, M. Scott, D. Weissman, C. Marra, U. G. Lalloo, and G. H. Friedland on behalf of the Tugela Ferry Care and Research (TF CARES) Collaboration. 2010. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. American Journal of Respiratory and Critical Care Medicine 181:80-86.

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

Garcia-Contreras, L., J. Fiegel, M. J. Telko, K. Elbert, A. Hawi, M. Thomas, J. VerBerkmoes, W. A. Germishuizen, P. B. Fourie, A. J. Hickey, and D. Edwards. 2007. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrobial Agents and Chemotherapy 51(8):2830-2836.

Government of India. 2001. Census Data 2001; India at a Glance; Broad Age Groups. http://www.censusindia.gov.in/Census_Data_2001/India_at_glance/broad.aspx (accessed March 22, 2012).

Government of India. 2011. Provisional Population Totals. Paper 1 Chapter 3: Size, Growth Rate and Distribution of Population; Census 2011. http://www.censusindia.gov.in/2011-prov-results/prov_results_paper1_india.html (accessed March 22, 2012).

Ha, D. T., N. T. Lan, M. Wolbers, T. N. Duong, N. D. Quang, T. Thi Van Thinh, L. Thi Hong Ngoc, N. Thi Ngoc Anh, T. Van Quyet, N. Thi Bich Tuyen, V. Thi Ha, J. Day, H. Thi Thanh Hang, V. S. Kiet, N. Thi Nho, D. V. Hoa, N. H. Dung, N. Huu Lan, J. Farrar, and M. Caws. 2009. Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS ONE 4(12):e8341.

Hazarika, I. 2011. Role of private sector in providing tuberculosis care: Evidence from a population-based survey in India. Journal of Global Infectious Diseases 3(1):19-24.

Heller, T., R. J. Lessells, C. G. Wallrauch, T. Bärnighausen, G. S. Cooke, L. Mhlongo, I. Master, and M. L. Newell. 2010. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. International Journal of Tuberculosis and Lung Disease 14(4):420-426.

ICMR (Indian Council of Medical Research). 1968. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. I: Findings in urban clinics among patients giving no history of previous chemotherapy. Indian Journal of Medical Research 56:1617-1630.

ICMR. 1969. Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. II. Findings in urban clinics among all patients, with or without history of previous chemotherapy. Indian Journal of Medical Research 57:823-835.

IIPS (International Institute for Population Sciences) and Macro International. 2007. National Family Health Survey (NFHS-3), 2005-06: India: Volume I. Mumbai: IIPS.

IOM (Institute of Medicine). 2009. Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge. Washington, DC: The National Academies Press.

IOM. 2011a. The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions. Washington, DC: The National Academies Press.

IOM. 2011b. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective. Washington, DC: The National Academies Press.

Jackson, S., A. C. Sleigh, G. J. Wang, and X. L. Liu. 2006. Poverty and the economic effects of TB in rural China. International Journal of Tuberculosis and Lung Disease 10(10):1104-1110.

Kawai, V., G. Soto, R. H. Gilman, C. T. Bautista, L. Caviedes, L. Huaroto, E. Ticona, J. Ortiz, M. Tovar, V. Chavez, R. Rodriguez, A. R. Escombe, and C. A. Evans. 2006. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. American Journal of Tropical Medicine and Hygiene 75(6):1027-1033.

Keshavjee, S. 2011a. Setting the Stage: Global Challenges in Drug-Resistant Tuberculosis and Potential Solutions. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 18, New Delhi, India.

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

Keshavjee, S. 2011b. Overview of Global Drug-Resistant Tuberculosis Burden. Speaker presentation of slides developed by Matteo Zignol (WHO/STOP TB Department) at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 18, New Delhi, India.

Keshavjee, S., I. Y. Gelmanova, P. E. Farmer, S. P. Mishustin, A. K. Strelis, Y. G. Andreev, A. D. Pasechnikov, S. Atwood, J. S. Mukherjee, M. L. Rich, J. L. Furin, E. A. Nardell, J. Y. Kim, and S. S. Shin. 2008. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: A retrospective cohort study. Lancet 372(9647):1403-1409.

Keshavjee, S., and K. Seung. 2008. Stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic. http://www.iom.edu/~/media/Files/Activity%20Files/Research/DrugForum/IOM_MDRTB_whitepaper_2009_01_14_FINAL_Edited.pdf (accessed September 15, 2011).

Khan, A. 2011. Mobile Technology to Improve Drug-Resistant TB Control and Management in Karachi. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Kim, S. J., M. A. Espinal, C. Abe, G. H. Bai, F. Boulahbal, L. Fattorin, C. Gilpin, S. Hoffner, K. M. Kam, N. Martin-Casabona, L. Rigouts, and V. Vincent. 2004. Is second-line anti-tuberculosis drug susceptibility testing reliable? International Journal of Tuberculosis and Lung Disease 8(9):1157-1158.

Krishnamurthy, A., C. Rodrigues, and A. P. Mehta. 2002. Rapid detection of rifampicin resistance in M. tuberculosis by phage assay. Indian Journal of Medical Microbiology 20:211-214.

Llerena, C., S. E. Fadul, M. C. Garzón, G. Mejía, D. L. Orjuela, L. M. García, H. B. Álvarez, and F. J. Ruiz. 2010. Drug-resistant Mycobacterium tuberculosis in children under 15 years. Biomedica 30(3):362-370.

Loudon, R. G., R. A. Frantz Jr., and C. A. LeMaistre. 1969. Laboratory for the study of mycobacterial aerosols. American Review of Respiratory Disease 100(2):160-164.

Marras, T. K., J. Wilson, E. E. Wang, M. Avendano, and J. W. Yang. 2003. Tuberculosis among Tibetan refugee claimants in Toronto: 1998 to 2000. Chest 124(3):915-921.

Menzies, D. 1997. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infection Control and Hospital Epidemiology 18(8):582-586.

Mitnick, C. D., J. Bayona, E. Palacios, S. Shin, J. Furin, F. Alcántara, E. Sánchez, M. Sarria, M. Becerra, M. C. Fawzi, S. Kapiga, D. Neuberg, J. H. Maguire, J. Y. Kim, and P. Farmer. 2003. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine 348(2):119-128.

Mitnick, C. D., S. S. Shin, K. J. Seung, M. L. Rich, S. S. Atwood, J. J. Furin, G. M. Fitzmaurice, F. A. Alcantara Viru, S. C. Appleton, J. N. Bayona, C. A. Bonilla, K. Chalco, S. Choi, M. F. Franke, H. S. Fraser, D. Guerra, R. M. Hurtado, D. Jazayeri, K. Joseph, K. Llaro, L. Mestanza, J. S. Mukherjee, M. Muñoz, E. Palacios, E. Sanchez, A. Sloutsky, and M. C. Becerra. 2008. Comprehensive treatment of extensively drug-resistant tuberculosis. New England Journal of Medicine 359(6):563-574.

Mohapatra, P. R. 2010. Lesson from surveillance of drug-resistant tuberculosis in Gujarat. Indian Journal of Medical Research 132:103-104.

Mondal, R., and A. Jain. 2007. Extensively drug-resistant Mycobacterium tuberculosis isolates, India [letter]. Emerging Infectious Diseases 13(9):1429-1431.

MSF (Médecins Sans Frontières) and IUATLD (International Union Against Tuberculosis and Lung Disease). 2011. DR-TB Drugs Under the Microscope: Sources and Prices for Drug-Resistant Tuberculosis Medicines. http://www.msfaccess.org/content/dr-tb-drugs-under-microscope (accessed November 16, 2011).

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

Myneedu, V. P., P. Visalakshi, A. K. Verma, D. Behera, and M. Bhalla. 2011. Prevalence of XDR TB cases—A retrospective study from a tertiary care TB hospital. International Journal of Tuberculosis and Lung Disease 58(2):54-59.

Narayanan, S., S. Swaminathan, P. Supply, S. Shanmugam, G. Narendran, L. Hari, R. Ramachandran, C. Locht, M. S. Jawahar, and P. R. Narayanan. 2010. Impact of HIV infection on the recurrence of tuberculosis in South India. Journal of Infectious Diseases 201(5):691-703.

Nardell, E., and A. Dharmadhikari. 2010. Turning off the spigot: Reducing drug-resistant tuberculosis transmission in resource-limited settings. International Journal of Tuberculosis and Lung Disease 14(10):1233-1243.

Nelson, L. J., Y. Naik, K. Tsering, and J. P. Cegielski. 2005. Population-based risk factors for tuberculosis and adverse outcomes among Tibetan refugees in India, 1994-1996. International Journal of Tuberculosis and Lung Disease 9(9):1018-1026.

Paramasivan, C. N., E. Lee, K. Kao, M. Mareka, G. Kubendiran, T. A. Kumar, S. Keshavjee, H. Satti, G. Alabi, M. Raviglione, and G. Roscigno. 2010. Experience establishing tuberculosis laboratory capacity in a developing country setting. International Journal of Tuberculosis and Lung Disease 14(1):59-64.

Paramasivan, C. N., and P. Venkataraman. 2004. Drug resistance in tuberculosis in India. Indian Journal of Medical Research 120(4):377-386.

Pereira, M., S. Tripathy, V. Inamdar, K. Ramesh, M. Bhavsar, A. Date, R. Iyyer, A. Acchammachary, S. Mehendale, and A. Risbud. 2005. Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian Journal of Medical Research 121(4):235-239.

Planning Commission of India. 2011. High Level Expert Group Report on Universal Health Coverage for India. http://planningcommission.nic.in/reports/genrep/rep_uhc0812.pdf (accessed April 13, 2012).

Ramachandran, P., S. Nalini, V. Chandrasekar, P. V. Dave, A. S. Sanghvi, F. Wares, C. N. Paramasivan, P. R. Narayanan, S. Sahu, M. Parmar, S. Chadha, P. Dewan, and L. S. Chauhan. 2009. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. International Journal of Tuberculosis and Lung Disease 13(9):1154-1160.

Ramachandran, P., and R. Prabhakar. 1992. Defaults, defaulter action and retrieval of patients during studies on tuberculous meningitis in children. Tubercle and Lung Disease 73(3):170-173.

Riley, R. L., C. C. Mills, W. Nyka, N. Weinstock, P. B. Storey, L. U. Sultan, M. C. Riley, and W. F. Wells. 1959. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. American Journal of Epidemiology 142(1):3-14.

Riley, R. L., C. C. Mills, F. O’Grady, L. U. Sultan, F. Wittstadt, and D. N. Shivpuri. 1962. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: Comparative infectiousness of different patients. American Review of Respiratory Disease 85:511-525.

RNTCP Status Report. 2007. TB India 2007. Central TB Division, DGHS, MoHFW. New Delhi: Government of India.

RNTCP Status Report. 2011. TB India 2011. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. New Delhi: Government of India. http://tbcindia.nic.in/pdfs/RNTCP%20TB%20India%202011.pdf (accessed March 21, 2012).

Robledo, J., G. I. Mejia, L. Paniagua, A. Martin, and A. Guzmán. 2008. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method. International Journal of Tuberculosis and Lung Disease 12(12):1482-1484.

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

Rodrigues, C., J. Jani, S. Shenai, P. Thakkar, S. Siddiqi, and A. Mehta. 2008. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. International Journal of Tuberculosis and Lung Disease 12(12):1449-1455.

Rouillon, A., S. Perdrizet, and R. Parrot. 1976. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 57(4):275-299.

Sachdeva, K. S. 2011. Overview of Drug-Resistant TB in India and National Scale Up of MDR TB Diagnosis and Treatment. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 18, New Delhi, India.

Satyanarayana, S., S. A. Nair, S. S. Chadha, R. Shivashankar, G. Sharma, S. Yadav, S. Mohanty, V. Kamineni, N. C. Wilson, A. D. Harries, and P. K. Dewan. 2011. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS ONE 6(9):e24160.

Saxena, P. 2011. Implementation of MDR-TB Programme in India—Successes and Challenges in Second-Line Anti-TB Drugs Management. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Schaaf, H. S., B. J. Marais, A. C. Hesseling, W. Brittle, and P. R. Donald. 2009. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa—An upward trend. American Journal of Public Health 99(8):1486-1490.

Schaaf, H. S., K. Shean, and P. R. Donald. 2003. Culture confirmed multidrug resistant tuberculosis: Diagnostic delay, clinical features, and outcome. Archives of Disease in Childhood 88(12):1106-1111.

Shanmugam, S., N. Selvakumar, and S. Narayanan. 2011. Drug resistance among different genotypes of Mycobacterium tuberculosis isolated from patients from Tiruvallur, South India. Infection, Genetics and Evolution 11(5):980-986.

Sharma, S. K., N. George, T. Kadhiravan, P. K. Saha, H. K. Mishra, and M. Hanif. 2009. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A retrospective hospital-based study. Indian Journal of Medical Research 130:392-395.

Sharma, S. K., G. Kaushik, B. Jha, N. George, S. K. Arora, D. Gupta, U. Singh, M. Hanif, and R. P. Vashisht. 2011a. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian Journal of Medical Research 133(3):308-311.

Sharma, S. K., S. Kumar, P. K. Saha, N. George, S. K. Arora, D. Gupta, U. Singh, M. Hanif, and R. P. Vashisht. 2011b. Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian Journal of Medical Research 133(3):312-315.

Sharma, S. K., R. Sarin, U. K. Khalid, N. Singla, P. P. Sharma, and D. Behera. 2008. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India. International Journal of Tuberculosis and Lung Disease 12(1):74-80.

Shin, S., J. Furin, J. Bayona, K. Mate, J. Y. Kim, and P. Farmer. 2004. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Social Science and Medicine 59:1529-1539.

Shin, S. S., A. D. Pasechnikov, I. Y. Gelmanova, G. G. Peremitin, A. K. Strelis, Y. G. Andreev, V. T. Golubchikova, T. P. Tonkel, G. V. Yanova, M. Nikiforov, A. Yedilbayev, J. S. Mukherjee, J. J. Furin, D. J. Barry, P. E. Farmer, M. L. Rich, and S. Keshavjee. 2006. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. International Journal of Tuberculosis and Lung Disease 10(4):402-408.

Singh, S., M. M. Sankar, and K. Gopinath. 2007. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients. AIDS 21(17):2345-2347.

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

Suchindran, S., E. S. Brouwer, and A. Van Rie. 2009. Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS ONE 4(5):e5561.

Swaminathan, S. 2011. Drug Resistant Tuberculosis in Children. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Swaminathan, S., C. N. Paramasivan, C. Ponnuraja, S. Iliayas, S. Rajasekaran, and P. R. Narayanan. 2005. Anti-tuberculosis drug resistance tuberculosis in patients with HIV and tuberculosis in South India. International Journal of Tuberculosis and Lung Disease 9(8):896-900.

TB Alliance (Global Alliance for TB Drug Development). 2007. Pathway to Patients: Charting the Dynamics of the Global TB Drug Market. India Case Study. http://www.tballiance.org/downloads/publications/study07/India_Case_Study.pdf (accessed March 26, 2012).

Treatment Action Group. 2011. Tuberculosis Research & Development: 2011 Report on Tuberculosis Research Funding Trends, 2005-2010. http://www.stoptb.org/assets/documents/resources/publications/acsm/TAG%20TB%20R&D%202011%20Report.pdf (accessed October 26, 2011).

Trindade, S., A. Sousa, K. B. Xavier, F. Dionisio, M. G. Ferreira, and I. Gordo. 2009. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genetics 5(7):e1000578.

Truong, D. H., L. L. Hedemark, J. K. Mickman, L. B. Mosher, S. E. Dietrich, and P. W. Lowry. 1997. Tuberculosis among Tibetan immigrants from India and Nepal in Minnesota, 1992-1995. Journal of the American Medical Association 277(9):735-738.

Udwadia, Z. F., R. A. Amale, K. K. Ajbani, and C. Rodrigues. 2012. Totally drug-resistant tuberculosis in India. Clinical Infectious Diseases 54(4):579-581.

Udwadia, Z. F., L. M. Pinto, M. W. Uplekar. 2010. Tuberculosis management by private practitioners in Mumbai, India: Has anything changed in two decades? PLoS ONE 5(8):e12023.

Van Deun, A., A. Wright, M. Zignol, K. Weyer, and H. L. Rieder. 2011. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. International Journal of Tuberculosis and Lung Disease 15(1):116-124.

WHA (World Health Assembly). 2009. Prevention and Control of Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. http://apps.who.int/gb/ebwha/pdf_files/A62/A62_R15-en.pdf (accessed December 6, 2011).

WHO (World Health Organization). 1996. Groups at Risk: WHO Report on the Tuberculosis Epidemic. Geneva, Switzerland: WHO.

WHO. 2008. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: Emergency Update 2008. Geneva, Switzerland: WHO Press.

WHO. 2010a. 2010/2011 Tuberculosis Global Facts. http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf (accessed September 15, 2011).

WHO. 2010b. Global Tuberculosis Control: WHO Report 2010. http://www.who.int/tb/publications/global_report/2010/en/index.html (accessed September 18, 2011).

WHO. 2010c. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. http://www.who.int/tb/features_archive/m_xdrtb_facts/en/index.html (accessed November 22, 2011).

WHO. 2011a. Global Tuberculosis Control: WHO Report 2011. http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf (accessed November 15, 2011).

WHO. 2011b. Towards Universal Access to Diagnosis and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by 2015: WHO Progress Report 2011. http://www.who.int/tb/publications/2011/mdr_report_2011/en/index.html (accessed November 22, 2011).

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×

WHO. 2011c. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. http://www.who.int/tb/challenges/mdr/programmatic_guidelines_for_mdrtb/en/index.html (accessed December 5, 2011).

World Economic Forum. 2008. Tackling Tuberculosis: The Business Response. http://members.weforum.org/pdf/GHI/TB.pdf (accessed April 19, 2012).

Wright, A., M. Zignol, A. Van Deun, D. Falzon, S. R. Gerdes, K. Feldman, S. Hoffner, F. Drobniewski, L. Barrera, D. van Soolingen, F. Boulabhal, C. N. Paramasivan, K. M. Kam, S. Mitarai, P. Nunn, M. Raviglione, and Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2009. Epidemiology of antituberculosis drug resistance 2002-07: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373(9678):1861-1873.

Yadav, P. 2011. MDR-TB: Challenges in Drug Supply Chain Logistics. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Zignol, M., W. van Gemert, D. Falzon, C. Sismanidis, P. Glaziou, K. Floyd, and M. Raviglione. 2012. Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007-2010. Bulletin World Health Organization 90:111D-119D.

Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 121
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 122
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 123
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 124
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 125
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 126
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 127
Suggested Citation:"References." Institute of Medicine. 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington, DC: The National Academies Press. doi: 10.17226/13243.
×
Page 128
Next: Appendix A: Workshop Agenda »
Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research Get This Book
×
Buy Paperback | $52.00 Buy Ebook | $41.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions.

The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!